Skip to main content
OpenTrials

Clinical trial condition

Chronic Obstructive Pulmonary Disease (COPD)

Explore clinical trials studying Chronic Obstructive Pulmonary Disease (COPD). Study availability and eligibility vary by location and protocol.

428 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Chronic Obstructive Pulmonary Disease (COPD) trial results

Completed

Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients

NCT01727024

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Novartis Investigative Site Goiânia, Goiás, Brazil
  • Novartis Investigative Site Belo Horizonte, Minas Gerais, Brazil
  • Novartis Investigative Site Belo Horizonte, Minas Gerais, Brazil
  • Novartis Investigative Site Rio de Janeiro, Brazil
View Trial Details
Completed

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)

NCT00297102

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Altana Pharma/Nycomed Investigational Site Fullerton, California, United States
  • Altana Pharma/Nycomed Investigational Site Los Angeles, California, United States
  • Altana Pharma/Nycomed Investigational Site Los Angeles, California, United States
  • Altana Pharma/Nycomed Investigational Site Palmdale, California, United States
View all 179 locations
View Trial Details
Completed

Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients.

NCT01120093

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Almirall Investigational Sites#1 Ghent, Belgium
  • Almirall Investigational Sites#3 Berlin, Germany
  • Almirall Investigational Sites#4 Berlin, Germany
  • Almirall Investigational Sites#9 Berlin, Germany
View Trial Details
Completed

A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT00363896

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Almirall Investigational Sites#947 Les Escaldes, Andorra
  • Almirall Investigational Sites#645 Graz, Austria
  • Almirall Investigational Sites#646 Innsbruck, Austria
  • Almirall Investigational Sites#644 Linz, Austria
View all 132 locations
View Trial Details
Completed

Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT01462929

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Almirall Investigational Site #9 Humpolec, Czechia
  • Almirall Investigational Site #1 Jaroměř, Czechia
  • Almirall Investigational Site #3 Mělník, Czechia
  • Almirall Investigational Site #4 Berlin, Germany
View all 41 locations
View Trial Details
Completed

Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)

NCT00358436

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Almirall Investigational Sites#926 Jasper, Alabama, United States
  • Almirall Investigational Sites#858 Ozark, Alabama, United States
  • Almirall Investigational Sites#900 Phoenix, Arizona, United States
  • Almirall Investigational Sites#899 Tucson, Arizona, United States
View all 120 locations
View Trial Details
Completed

Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT01471171

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Almirall Investigational Site #10 Berlin, Germany
  • Almirall Investigational Site #6 Berlin, Germany
  • Almirall Investigational Site #2 Berlin, Germany
  • Almirall Investigational Site #4 Frankfurt, Germany
View all 14 locations
View Trial Details

Related conditions